Epitalon peptide quality: purity testing, COA, and laboratory verification

September 4, 2026

Epitalon, also referred to as Epithalon, is a tetrapeptide described by the sequence Ala-Glu-Asp-Gly, abbreviated as AEDG. The analytical characterization of this compound encompasses several distinct issues: chemical identity, chromatographic purity, peptide content, presence of other components, and changes in material properties over time.

A single percentage value does not provide a full description of the sample. The purity result does not necessarily determine the identity, quantity, or stability of the substance at the same time. Also, the document entitled „certificate of analysis” presents information on a specific scope of testing, rather than a universal confirmation of all properties of the material.

In the scientific description of Epitalon's quality, therefore, it is important to distinguish what was actually measured from what cannot be determined on the basis of a given measurement. This applies to both a single chromatogram and extensive laboratory documentation.

What does the analytical characteristic of Epitalon mean?

Analytical characterization consists in describing the composition and properties of a material using appropriate testing. It is not a single measurement, but a set of information answering various questions.

When it comes to Epitalon, the primary issue is the compliance of the data with the expected AEDG molecule. Subsequent issues concern the quantity of this substance, the presence of additional ingredients, and the extent of changes occurring in the material.

Parameter	Which question does it describe?	What does he not resolve on his own?
Chemical identity	Do the data correspond to the expected molecule?	How much of this substance is in the sample?
Chromatographic purity	What signal share was assigned to a specific component?	Does the result correspond to the mass fraction in the entire sample?
Peptide Content	How much of the labeled peptide is present in the sample?	Have all the other ingredients been characterized?
Contaminant profile	What other substances were detected?	Have all possible contaminants been ruled out?
Chemical species	How is the chemical form of the material described?	Does the material remain unchanged over time?
Stability	Do specific parameters change over time?	Have properties outside the scope of the observations been studied?

Such a distinction prevents treating a single result as the answer to all questions regarding the sample. The material may contain a correctly identified peptide while simultaneously requiring separate quantification of its content or characterization of the remaining components.

Chemical identity — what does the AEDG sequence mean?

The sequence Ala-Glu-Asp-Gly describes the order of four amino acid residues: alanine, glutamic acid, aspartic acid, and glycine. The abbreviation AEDG uses the one-letter symbols for these amino acids.

The name of the substance and its sequence record are elements of the chemical description. However, they do not constitute the test result of the sample in themselves. The information included in the documentation specifies the expected identity, whereas the analysis provides data allowing to assess the compliance of the material with this description.

It is also important to distinguish between a sequence and the complete characterization of a material. A sequence does not automatically describe the water content, counterions, additives, or other substances present in the sample.

Two materials described by the same name may therefore require separate analytical characterization. Consistency in nomenclature does not replace the comparison of results.

What is a Certificate of Analysis (COA)?

COA is an abbreviation for the English term Certificate of Analysis. The document presents the results of analyses relating to an identified material, sample, or batch.

The certificate may contain the substance name, sample designation, batch identifier, testing date, analytical methods, obtained results, and evaluation criteria. Individual documents differ in scope and level of detail.

The mere presence of the abbreviation “COA” does not indicate whether only a chromatographic analysis, identification, or quantification was performed, or whether a broader set of analyses was conducted. The meaning of the document is determined by its content.

Test result vs specification

The specification describes the established requirements or evaluation criteria. The test result represents the outcome obtained for a specific sample.

In the documentation, both types of information may be located next to each other. However, the limit value in the „specification” column is not the same as the measured value.

Similarly, the entry „compliant” implies a comparison of the result against a specific criterion. Without information about this criterion and the methodology, it does not present a complete picture of the assessment performed.

Numerical result versus descriptive result

Not every analysis leads to a numerical value. An identification test may end with a descriptive statement of compliance with the expected material, whereas a content determination usually presents a quantitative result.

The lack of a number does not automatically mean a lack of scientific value. What matters is whether the form of the result corresponds to the purpose of the study and whether it is known on what basis the conclusion was formulated.

On the other hand, the mere presence of many numbers does not prove that the document describes all the relevant properties of the sample.

COA and full analytical report

The certificate may serve as a summary of more extensive documentation. Chromatograms, spectra, calculations, and method details may be included in a separate laboratory report.

The lack of a chromatogram in the COA itself does not prove that chromatography was not performed. However, it means that the signal profile cannot be analyzed in detail based on this document.

Similarly, the attached chromatogram is only part of the documentation. Its interpretation depends on its association with the method, sample, and the method of calculating the result.

What does HPLC describe in the analysis of Epitalon?

HPLC, or high-performance liquid chromatography, is a technique for separating sample components. Compounds that differ in their interactions within a specific chromatographic system can be recorded as separate peaks.

The chromatogram shows the detector response over time. Information about peak position, shape, and area is interpreted in relation to a specific method.

In peptide analysis, chromatography can provide data on the main component and accompanying substances. However, its capabilities are not unlimited: not every method separates all compounds and not every component is detected equally well.

Retention time

Retention time describes the moment a specific component is detected in a given chromatographic system. It is a feature dependent on the analysis conditions.

It should not be treated as an invariant molecular identifier, independent of the method used. The same compound may have a different retention time in a different system, and different compounds may exhibit similar times in a single analysis.

Compliance of the retention time can be an element of comparison, but its significance stems from the entire analytical context.

Peak area

Peak area refers to the integrated detector signal. Its interpretation depends, among other things, on the detector's response to a given component.

It is not an independent, universal measurement of the mass of a substance. In the quantitative method, the relationship between the signal and the amount of analyte requires proper determination.

Therefore, the chromatogram used to assess the relative peak area does not necessarily have to represent the determination of the total Epitalon content.

Does one peak mean one substance?

Not always. Various components may not be separated and form an overlapping signal. This phenomenon is referred to as co-elution.

The dominant peak therefore does not independently confirm that it contains solely a single compound. It also does not prove that this compound has the expected identity.

Evaluation of chromatographic homogeneity and confirmation of chemical structure remain distinct issues.

What does chromatographic purity mean?

If the result was calculated by peak area normalization, it describes the share of the selected peak in the sum of areas included in the calculation.

This value pertains to the signal obtained under specific conditions. It does not necessarily correspond to the mass fraction of the peptide in the entire material.

Among other things, the resolution of the method, the type of detector, the detectability of individual substances, and the integration principles are important.

Why does a percentage result require context?

Different components can generate a different detector response. Some may be detected poorly, while others may remain outside the scope of a given analysis.

Water, specific inorganic components or other substances do not need to be included in the peak area calculation. A high proportion of the main signal therefore does not automatically mean that the entire material consists almost exclusively of the peptide.

Also, small differences between percentage results do not always allow samples to be ranked by quality. Without knowledge of the methods and their properties, the comparison can be ambiguous.

What does mass spectrometry describe?

Mass spectrometry, abbreviated as MS, analyzes ions based on their mass-to-charge ratio. This data can support the assessment of whether the tested component matches the expected molecule.

The method provides a different kind of information than chromatography. Chromatography separates components in a specific system, whereas mass spectrometry describes the properties of the registered ions.

The combination of these techniques, namely LC-MS, enables the correlation of chromatographic information with mass information.

Molecular mass versus mass-to-charge ratio

On a mass spectrum, the mass-to-charge ratio is presented, usually denoted as m/z. Each value on the spectrum axis should not be directly equated with the mass of a neutral molecule.

The interpretation takes into account the type of the registered ion and its charge. A mere reading of a single number, without signal assignment, does not constitute a full identification.

The identification report links the observed signals with the expected properties of the tested compound.

Mass compliance and full structure

Mass compliance is evidence of a specific scope. It does not always resolve all issues concerning the structure of the molecule.

Some compounds may have the same mass despite structural differences. Some issues related to isomerism or stereochemistry require additional information.

Tandem mass spectrometry, or MS/MS, analyzes ion fragmentation and can provide further structural data. The scope of possible conclusions still depends on the specific problem and the applied analysis.

Does the MS signal alone determine the content?

Detecting the signal assigned to a peptide does not automatically mean quantifying it.

MS can be part of a quantitative method, but this requires appropriate development and calibration. A result obtained solely for identification purposes does not replace such a procedure.

It also cannot be assumed that the strongest signal in the spectrum always corresponds to the largest mass fraction of the component.

Why are HPLC and MS complementary methods?

Both techniques describe different sample properties. Their combination can limit the ambiguity of interpretation, but it does not automatically create a complete material characterization.

Chromatography can show the presence of a dominant component. Mass information can support the assignment of this component to the expected molecule.

However, questions regarding quantitative content, undetected components, chemical form, or stability still remain. The scope of the answer depends on the measurements actually performed.

The concept of complementary methods therefore implies a combination of various evidence concerning the same material. It does not mean that any two results are sufficient to resolve all aspects of quality.

Why does the peptide content require separate determination?

The content describes the amount of the quantified substance in the sample. It differs from the relative contribution of the chromatographic signal.

The total mass of the material may include peptide, water, counterions, excipients, and other substances. The individual components do not necessarily have to be represented in the chromatogram in a manner corresponding to their mass.

Therefore, the percentage of the peak area should not be automatically used as a conversion factor for the actual amount of the peptide.

Base of the expression of the result

A quantitative result requires an indication of what it refers to. It may describe the material as received, dry weight, or another specified basis.

Two numbers presented in similar units may have different meanings if they were calculated with respect to different forms of the material.

The documentation should make it possible to distinguish between the measured quantity and the way it is represented. Without this, comparing results can lead to apparent contradictions.

What role does the reference material play?

A reference material serves as a comparison point for specific analytical properties. It can participate in identification or in establishing the relationship between the signal and the quantified amount.

Its meaning depends on which properties have been characterized and for what purpose it is used. The name „pattern” itself does not describe the full range of its assigned features.

Comparison with the reference material also does not mean that both samples are identical in every respect. The conclusion applies to those parameters that were included in the comparison.

Contraions, water, and excipients

The peptide material may contain substances that are not part of the amino acid sequence. Their presence affects the description of the entire sample.

A counterion is an accompanying ion to an oppositely charged component. Its type and content constitute separate information from the peptide's name and sequence.

A specific counterion should not be assumed solely on the basis of the term „Epitalon”. The characterization of a given form requires appropriate information regarding the material.

Similarly, neither the water content nor the excipients can be reliably determined from the appearance of the powder. The volume and shape of the dry sample do not describe its quantitative composition.

The presence of a specific additive component does not in itself determine whether the material complies with the specification. It is essential whether this component has been defined and characterized.

What does a pollution profile mean?

The impurity profile describes additional substances detected within the scope of the performed analyses. It may include compounds related to the synthesis, purification, or transformation of the material.

In the case of synthetic peptides, various types of accompanying substances are possible. Their presence depends on the specific sequence and the history of the sample.

However, general knowledge about peptide impurities does not prove the presence of a specific compound in Epitalon. A conclusion regarding a specific material requires direct data.

Identified and unidentified contaminants

An additional peak may indicate the presence of a component whose identity has not yet been established. Signal detection and substance identification are different stages of characterization.

Not every small peak can be automatically assigned to a specific degradation product. Such an assignment requires appropriate evidence.

On the other hand, the lack of full identification of the additional component does not mean that its signal is irrelevant to the sample's characteristics.

Non-detection vs. absence

The „not detected” information refers to the capability of a specific test. It is not proof of the absolute absence of the substance.

A target-specific analysis does not automatically describe all other potential ingredients. The scope of the conclusion remains tied to the scope of the method.

Therefore, in scientific documentation, it is important to distinguish the absence of a signal from the universal statement that the sample contains no contaminants.

Why do the properties of an analytical method matter?

A technique name, such as HPLC or MS, does not describe the entire procedure. Two methods using the same technique can be developed for different purposes.

One may serve mainly for identification, another for designating content, and yet another for separating specific impurities. Their results should not be treated as interchangeable solely due to the shared name of the apparatus.

The ICH Q2(R2) guideline describes the evaluation of analytical procedures with respect to their purpose. It lists, among other things, accuracy, precision, specificity, and limits of detection and quantitation. Its scope applies to specific pharmaceutical analyses; the reference to the document does not grant Epitalon the status of an approved product. Source: EMA, ICH Q2(R2).

Even the phrase „validated method” requires context. Validation refers to a defined purpose and scope, and not to all possible measurements.

Sample and batch traceability

Traceability enables the connection of a result to the material under investigation. This is achieved through sample markings, batch identifiers, report numbers, and laboratory records.

It is not the same as representativity. A properly labeled sample can be uniquely linked to the report, but extending the result to the entire batch requires additional justification.

Sample and batch

The sample is the material subjected to analysis. The batch covers a broader collection of material specified in the documentation.

Sampling does not mean testing every part of the batch. The scope of possible generalizations depends, among other things, on the sampling method and data regarding homogeneity.

Number matching documents the connection, but does not independently confirm the identical composition of all units.

External laboratory

The information that the analysis was performed by an external laboratory describes the organization that conducted the test. It does not independently determine its scope or the properties of the applied method.

Scientific significance results from documented measurement. The term „independently tested” does not replace information about the sample, analysis, and results.

The authenticity of the document, the validity of the method, and the representativeness of the sample are separate issues.

Chemical purity vs. microbiological parameters

Chemical purity and microbiological parameters describe different material properties. A result for one area does not automatically provide information about the other.

Neither the standard HPLC chromatogram nor the MS identification result confirms sterility, nor do they replace endotoxin testing.

Sterility, microbial presence, and endotoxin content are not interchangeable concepts. Documentation regarding one of these parameters does not have to cover the others.

Also, the lack of microbiological information does not allow predicting the outcome of the unperformed test. This represents a limitation of the available characterization.

What does the documentation say about stability?

Stability refers to the retention of specific material properties over time. Its evaluation requires data relating to defined parameters and conditions.

The initial purity result does not automatically describe the condition of the sample at any later time. The test date indicates when the analysis was performed, but it does not replace the observation of changes.

No visible differences do not confirm chemical stability either. Not all transformations lead to a change in color, the appearance of a precipitate, or another noticeable phenomenon.

A COA may contain information related to the stability assessment, but its significance depends on the data on which it was based. The summary document itself does not automatically reveal the entire course of such studies.

What are the limits of COA interpretation?

A certificate of analysis presents results within a specified range. It does not constitute independent proof of the full characterization of all components, the identity of the entire batch, or the immutability of the material after testing.

It also does not confirm properties that have not been indicated. A lack of information is a gap in the available documentation, not a positive or negative result.

The phrase „Epitalon quality” therefore requires clarification: it can refer to identity, purity, content, or other parameters. Without this, it remains a general term.

The analytical results describe the material. They do not constitute confirmation of its suitability for use in humans or animals.

Frequently asked questions

What does the COA of Epitalon mean?

The Epitalon COA is a certificate of analysis presenting the results of specific tests on a sample or batch of material described as Epitalon. The document may include information on chemical identity, chromatographic purity, peptide content, or other designated parameters. Its significance depends on which analyses were actually performed, how the methods are described, and whether the results can be linked to a specific material. The name „certificate of analysis” alone does not indicate an identical scope of testing across all documents. A COA therefore constitutes a record of specific analytical findings, rather than a general confirmation of all properties of the substance.

Does chromatographic purity confirm identity?

Chromatographic purity does not independently confirm chemical identity, because it describes the contribution of a specific signal in the chromatogram rather than the complete structure of the substance responsible for that signal. A sample may exhibit a single dominant peak, but its assignment to Epitalon requires appropriate identification evidence. A high proportion of the main peak's area does not exclude a situation where it corresponds to another compound or several unresolved components. Therefore, the assessment of chromatographic purity and the identification of the compound answer different questions. Only the combination of appropriate data allows for describing both the nature of the main component and its contribution to the recorded signal.

Does one HPLC peak mean no contamination?

A single peak HPLC does not automatically mean there are no impurities, because the chromatogram only shows components that were separated and detected under the specific conditions of that method. Some substances may co-elute, meaning they leave the column at a similar time and produce an overlapping signal. Others may be below the detection limits or fail to generate a sufficient response from the detector used. A single dominant peak therefore indicates a specific chromatographic profile, but it does not provide a complete description of the sample's composition. Without additional information, the presence of components that are invisible in a given analysis cannot be ruled out on this basis alone.

Does the matching mass confirm the full structure?

The consistency of the mass spectrometry result with the expected value supports the identification of the compound, but does not in every situation confirm its complete structure. Different molecules can have the same mass despite having a different arrangement of atoms or stereochemical differences. Furthermore, the interpretation of the spectrum requires taking into account the type of registered ion and its charge, because the mass-to-charge ratio is measured. Additional data, such as fragmentation in MS/MS or the results of other relevant methods, can help resolve certain ambiguities. The scope of structural confirmation therefore depends on the entire set of evidence, rather than solely on the agreement of a single signal.

Are HPLC and MS interchangeable?

HPLC and mass spectrometry are not interchangeable methods because they provide information about different properties of the tested material. HPLC enables the separation of components in a specific chromatographic system, whereas MS analyzes ions based on their mass-to-charge ratio. Combining these techniques can link the chromatographic signal with information supporting the identification of a given component. However, this does not mean the automatic determination of all sample parameters. Quantitative content, the presence of specific additional components, stability, or microbiological parameters may require separate testing. The value of combining HPLC and MS stems from the complementarity of the data rather than the mutual substitution of the methods.

Does percentage purity mean peptide content?

The percentage of purity does not necessarily reflect the actual peptide content, because the meaning of the percentage value depends on how it was determined. If the result represents the area share of the main peak in the sum of the included chromatographic peaks, it refers to the recorded signal rather than directly to the total mass of the material. The sample may contain water, counterions, or other components that are not adequately reflected in such a calculation. Determining the peptide content requires an appropriate quantitative method and a clearly defined basis for the result. Chromatographic purity and content therefore remain distinct parameters, even when both are expressed as percentages.

Does the COA have to contain all raw data?

A COA may serve as a summary document and does not have to be a complete record of all data obtained during the analysis. Chromatograms, spectra, detailed calculations, and information about the testing process may be located in a separate report or laboratory documentation. The scope of required documentation depends on the relevant quality system and the testing context, so one rule should not be applied to all certificates. The absence of raw data in the COA itself does not prove that the analysis was not performed, but it limits the possibility of its detailed evaluation based on this document. Also, a single attached chart is not equivalent to complete analytical documentation.

Is „compliant” a test result?

The term „compliant” can be a valid summary of an evaluation where a result is compared against a previously defined criterion. However, it does not always present the measurement result itself or the detailed evidence forming the basis of this conclusion. In an identification test, it may signify the conformity of specific characteristics with a reference material, whereas in a quantitative determination, it may indicate that an accepted range has been met. The meaning of the record thus depends on the parameter tested, the method used, and the specification. Without this context, it is unclear what compliance precisely refers to, and it cannot be extended to material properties not covered by the evaluation.

Does a single-sample report describe the entire batch?

A single-sample report does not automatically describe the entire batch, as it directly presents the results for the material actually analyzed. The ability to relate these results to a broader batch depends on the sampling method, its representativeness, and data concerning the material's homogeneity. A matching batch number enables a documentary link between the sample and a specific set of material, but it does not in itself prove the identical composition of every part thereof. This does not mean that the result of a single sample is meaningless, but rather that the scope of generalization requires justification. Traceability and representativeness are related, yet distinct elements of interpretation.

Does an external audit guarantee full characterization?

A study conducted by an external laboratory does not guarantee a complete characterization, as it covers a specific set of analyses performed on the submitted material. The independence of the organization does not automatically expand the scope of measurements or provide information on properties that were not tested. The purpose of the analysis, the characteristics of the methods, the documentation of the results, and the way the sample is linked to the material remain essential. An authentic external report may present valuable data while leaving other parameters undescribed. Therefore, the term „independently tested” provides information about the organization performing the test, but does not replace a detailed description of what was actually established.

Does „not detected” mean the complete absence of the substance?

The term „not detected” does not mean proof of the complete absence of a substance, but rather informs that no signal meeting the detection criteria was found under the conditions of a specific analysis. The method has defined detection capabilities, and the sample composition and measurement method affect the scope of the information obtained. The substance may be present in an amount too small to be detected by the given procedure. Furthermore, testing targeted at a single component does not determine the presence of all other compounds. Therefore, such a record should be interpreted in relation to the quantified substance and the method, without transforming it into a general assurance of the absence of contaminants.

Does the appearance of the powder confirm its composition?

The appearance of the powder does not confirm its chemical composition, because color, volume, porosity, or degree of caking are physical characteristics insufficient for substance identification. Materials with different compositions may look similar, and materials containing the same peptide may differ in appearance. Observation does not determine the content of Epitalon, the amount of water, the type of counterion, or the presence of excipients. It also does not rule out invisible impurities or chemical transformations. A visual description can be part of the sample documentation, but it does not replace analytical testing and does not justify independent conclusions regarding its identity, purity, or stability.

Does chemical purity confirm sterility?

Chemical purity does not confirm sterility, because both concepts refer to different material properties. Chromatographic analysis describes specific chemical components detected by a given method, whereas the sterility assessment concerns a separate microbiological issue. A standard HPLC result or identification via MS does not replace appropriate microbiological testing. Also, sterility and endotoxin content are not interchangeable concepts, so the result regarding one parameter cannot be automatically applied to the other. High chromatographic purity therefore does not constitute a general confirmation of the sample's microbiological properties or its safety.

Does the initial COA confirm stability over time?

An initial COA alone does not confirm stability over time if it presents exclusively the results of a one-time analysis. Such a document describes the material with respect to the tests performed, whereas stability requires data concerning the behavior of specific properties under defined conditions and periods. The absence of visible changes does not rule out chemical transformations, just as the date of certificate issuance does not replace analytical observations. A COA may contain information based on separate stability studies, but their significance depends on the documentation underlying those records. An initial purity result alone does not allow one to assume the invariance of the material at any later point in time.

Is the COA a security guarantee?

A COA is not a guarantee of safety because it presents test results for specific material properties rather than a comprehensive assessment of all possible consequences of its use. Confirmation of a peptide's identity, purity, or content does not in itself establish the suitability of the substance for human or animal use. Nor does the document provide information on parameters not covered by the analysis. Therefore, even a detailed and authentic certificate must be interpreted in accordance with the scope of the documented measurements. Its function is to describe the tested material, not to replace separate evidence required for safety assessment.

Disclaimer

The article is exclusively for educational and informational purposes in the context of laboratory research. It does not constitute medical advice, product selection advice, injection instructions, or a recommendation for the use of Epitalon. Analytical confirmation of identity or purity does not confirm clinical safety, efficacy, sterility, or suitability for human administration. Appropriate quality control requirements depend on the intended laboratory use, and where peptide identity, purity, quantity, sterility, endotoxins, or stability are relevant to the experiment, the appropriate framework is provided by validated methods, qualified laboratories, and relevant institutional or regulatory standards.

References

Araj, S. K., Brzezik, J., Mądra-Gackowska, K., & Szeleszczuk, Ł. (2025). Overview of Epitalon—Highly bioactive pineal tetrapeptide with promising properties. International Journal of Molecular Sciences, 26(6), 2691.
https://doi.org/10.3390/ijms26062691
Vanhee, C., Moens, G., Van Hoeck, E., Deconinck, E., & De Beer, J. O. (2015). Identification of the small research tetra peptide Epitalon, assumed to be a potential treatment for cancer, old age and Retinitis Pigmentosa in two illegal pharmaceutical preparations. Drug Testing and Analysis, 7(3), 259–264.
https://doi.org/10.1002/dta.1771
McCarthy, D., Han, Y., Carrick, K., Schmidt, D., Workman, W., Matejtschuk, P., Duru, C., & Atouf, F. (2023). Reference standards to support quality of synthetic peptide therapeutics. Pharmaceutical Research, 40(6), 1317–1328.
https://doi.org/10.1007/s11095-023-03493-1
Sharma, N., Kukreja, D., Giri, T., Kumar, S., & Shah, R. P. (2022). Synthetic pharmaceutical peptides characterization by chromatography principles and method development. Journal of Separation Science, 45(13), 2200–2216.
https://doi.org/10.1002/jssc.202101034
Li, M., Josephs, R. D., Daireaux, A., Choteau, T., Westwood, S., Wielgosz, R. I., & Li, H. (2018). Identification and accurate quantification of structurally related peptide impurities in synthetic human C-peptide by liquid chromatography–high resolution mass spectrometry. Analytical and Bioanalytical Chemistry, 410(20), 5059–5070.
https://doi.org/10.1007/s00216-018-1155-y
International Council for Harmonisation. (2024). ICH Q2(R2): Validation of Analytical Procedures. Current guideline for validation of analytical methods used for purposes including identity, assay, purity and impurity testing.
https://www.ema.europa.eu/en/ich-q2r2-validation-analytical-procedures-scientific-guideline
U.S. FDA version:
https://www.fda.gov/media/161201/download